Article
Recombinant human bone morphogenetic protein‐2 and pancreatic cancer: a retrospective cohort study
9 Dec 2010
Abstract excerpt
PURPOSE: To assess whether use of recombinant human bone morphogenetic protein-2 (rhBMP-2) during lumbar spinal fusion surgery affects subsequent risk of pancreatic cancer. METHODS: Using US Medicare claims data, we performed a retrospective cohort study of patients who underwent lumbar spinal fusion surgery between October 2003 and December 2005. The study population, all >66 years, was identified from procedure...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
